Changes in mortality and morbidity in systemic lupus erythematosus;Entwicklung von Mortalität und Morbidität beim systemischen Lupus erythematodes

Zeitschrift fur Rheumatologie

Volumn 70, Issue 6, 2011, Pages 480-485

  Chehab, G ^a   Fischer Betz, R ^a   Schneider, M ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Disease progression; Lupus erythematosus; Morbidity; Mortality; Prognosis; Systemic

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; COMORBIDITY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; HUMAN; MORBIDITY; MORTALITY; PROGNOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADRENAL CORTEX HORMONES; ADULT; AGE FACTORS; AGED; ANTI-INFLAMMATORY AGENTS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COMORBIDITY; DISEASE PROGRESSION; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; PROGNOSIS; SURVIVAL RATE;

EID: 80054866265     PISSN: 03401855     EISSN: 14351250     Source Type: Journal    
DOI: 10.1007/s00393-011-0758-x     Document Type: Article

References (36)

1. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J (1995) Mortality studies in systemic lupus erythematosus. Results from a single center.I. Causes of death. J Rheumatol 22:1259-1264
2. Alamanos Y, Voulgari PV, Papassava M et al (2003) Survival and mortality rates of systemic lupus erythematosus patients in northwest Greece. Study of a 21-year incidence cohort. Rheumatology (Oxford) 42:1122-1123 (Pubitemid 37221011)
3. Alarcón GS, McGwin G, Bastian HM et al (2001) Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum 45:191-202 (Pubitemid 32954446)
4. Bernatsky S, Boivin J, Joseph L et al (2006) Mortality in systemic lupus erythematosus. Arthritis Rheum 54:2550-2557 (Pubitemid 44205016)
5. Bertsias G, Ioannidis JP, Boletis J et al (2008) EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis 67:195-205 (Pubitemid 351183308)
6. Blanco FJ, Gómez-Reino JJ, La Mata J de et al (1998) Survival analysis of 306 European Spanish patients with systemic lupus erythematosus. Lupus 7:159-163 (Pubitemid 28190679)
7. Bongu A, Chang E, Ramsey-Goldman R (2002) Can morbidity and mortality of SLE be improved? Best Pract Res Clin Rheumatol 16:313-332
8. Cervera R, Khamashta MA, Font J et al (1999) Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 78:167-175 (Pubitemid 29231143)
9. Cervera R, Khamashta MA, Font J et al (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 82:299-308 (Pubitemid 37229465)
10. Chiu M, Austin PC, Manuel DG, Tu JV (2010) Comparison of cardiovascular risk profiles among ethnic groups using population health surveys between 1996 and 2007. CMAJ 182:E301-310
11. Doria A, Iaccarino L, Ghirardello A et al (2006) Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 119:700-706 (Pubitemid 44128446)
12. Gladman DD, Hussain F, Ibañez D, Urowitz MB (2002) The nature and outcome of infection in systemic lupus erythematosus. Lupus 11:234-239 (Pubitemid 34506728)
13. Goldblatt F, Chambers S, Rahman A, Isenberg DA (2009) Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality. Lupus 18:682-689
14. Gordon MF, Stolley PD, Schinnar R (1981) Trends in recent systemic lupus erythematosus mortality rates. Arthritis Rheum 24:762-769 (Pubitemid 11117263)
15. Hochberg MC (1987) Mortality from systemic lupus erythematosus in England and Wales, 1974-1983. Br J Rheumatol 26:437-441 (Pubitemid 18005350)
16. Jacobsen S, Petersen J, Ullman S et al (1999) Mortality and causes of death of 513 Danish patients with systemic lupus erythematosus. Scand J Rheumatol 28:75-80 (Pubitemid 29173250)
17. Kang I, Park SH (2003) Infectious complications in SLE after immunosuppressive therapies. Curr Opin Rheumatol 15:528-534 (Pubitemid 37041388)
18. Kasitanon N, Magder LS, Petri M (2006) Predictors of survival in systemic lupus erythematosus. Medicine (Baltimore) 85:147-156 (Pubitemid 43833013)
19. Manger K, Manger B, Repp R et al (2002) Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis 61:1065-1070 (Pubitemid 35397352)
20. Manzi S, Meilahn EN, Rairie JE et al (1997) Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 145:408-415 (Pubitemid 27084212)
21. Mok C, Kwok C, Ho L et al (2011) Life expectancy, standardized mortality ratios and causes of death of six rheumatic diseases in Hong Kong, China. Arthritis Rheum 63(5):1182-1189
22. Mosca M, Tani C, Aringer M et al (2010) European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis 69:1269-1274
23. Navarra SV, Leynes MSN (2010) Infections in systemic lupus erythematosus. Lupus 19:1419-1424
24. Nossent J, Cikes N, Kiss E et al (2007) Current causes of death in systemic lupus erythematosus in Europe, 2000-2004: relation to disease activity and damage accrual. Lupus 16:309-317 (Pubitemid 47074831)
25. Petri M, Spence D, Bone LR, Hochberg MC (1992) Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort: prevalence, recognition by patients, and preventive practices. Medicine (Baltimore) 71:291-302
26. Petri M, Perez-Gutthann S, Longenecker JC, Hochberg M (1991) Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med 91:345-353
27. Rubin LA, Urowitz MB, Gladman DD (1985) Mortality in systemic lupus erythematosus: the bimodal pattern revisited. Q J Med 55:87-98 (Pubitemid 15105095)
28. Swaak AJ, Nossent JC, Smeenk RJ (1991) Prognostic factors in systemic lupus erythematosus. Rheumatol Int 11:127-132
29. Uramoto KM, Michet CJ, Thumboo J et al (1999) Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum 42:46-50 (Pubitemid 29042569)
30. Urowitz MB, Bookman AA, Koehler BE et al (1976) The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 60:221-225
31. Urowitz MB, Ibañez D, Gladman DD (2007) Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors. J Rheumatol 34:70-75 (Pubitemid 46106565)
32. Urowitz MB, Gladman DD, Tom BD M et al (2008) Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol 35:2152-2158
33. Walsh SJ, DeChello LM (2001) Geographical variation in mortality from systemic lupus erythematosus in the United States. Lupus 10:637-646 (Pubitemid 32959279)
34. Ward MM, Pyun E, Studenski S (1995) Long-term survival in systemic lupus erythematosus. Patient chaacteristics associated with poorer outcomes. Arthritis Rheum 38:274-283
35. Ward MM, Pyun E, Studenski S (1995) Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort. Arthritis Rheum 38:1492-1499
36. Ward MM, Pyun E, Studenski S (1996) Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch Intern Med 156:1337-1344 (Pubitemid 26196894)